- Open Access
Factors affecting men’s support for the use of the contraceptive implant by their female intimate partners
Contraception and Reproductive Medicine volume 5, Article number: 36 (2020)
Family planning services have been available at no cost in the public health settings of South Africa since 1994, and now include the long-acting reversible contraceptives (LARCs) namely, the contraceptive implant and intra-uterine device (IUD). However, the uptake of LARCs has been declining in the recent years and little is known about the cause of the decline. In many relationships, men may influence their female intimate partner’s contraceptive choices. Thus, men’s involvement in reproductive health decisions and family programming may improve their support for contraceptive use, including the LARC use by their female intimate partners. This study investigated factors affecting men’s support for the use of contraceptive implant by their female intimate partners.
A quantitative, cross-sectional survey was conducted among adult men attending a public, primary health clinic in Cape Town, South Africa. Using a structured questionnaire, we measured men’s knowledge, awareness and support of, and attitudes towards use of the contraceptive implant by their female intimate partners. Data were analyzed using SPSS version 25.
The sample included 65 men with a mean age of 31.2 years. Most (76.6%) believed that both men and women should be responsible for family planning. Support for general contraception use by their female intimate partners was prevalent at 80.0%, but only 33.9% reported that they would like their partners to use the implant in the future, while 35.6% were unsure and 30.5% did not support their partner’s use of the implant. Factors significantly associated with men’s support of their partner’s future use of the contraceptive implant included men’s reports that their partner wished to have another child in future, knowledge that the implant is safe for use by women who have not had children, knowledge that the implant can effectively prevent pregnancy for 3 years, and a positive attitude towards the implant’s long-lasting effectiveness.
Improving men’s knowledge of, and attitudes toward the contraceptive implant might increase their support for their partner’s use of the implant, which in turn might promote uptake of the implant among women. The findings of our study suggest the importance of actively engaging men in reproductive health and family planning programs.
Family planning services have been available at no cost in public health services in South Africa since 1994, and now include the long-acting reversible contraceptives (LARCs) namely, the contraceptive implant and intra-uterine device (IUD). The Department of Health’s (DoH) policy on contraception and fertility planning, updated in 2014, expanding the method mix to give women greater choice for family planning . According to the policy, “the methods of contraception were expanded to cover an increased access to LARC methods with with specific consideration of: increasing access to the copper intrauterine device (Cu IUD), with antibiotics at the time of insertion, and introduction of a single-rod progestogen implant…” . The contraceptive implant, Implanon NXT, was the most common LARC on offer in South African public health services at no cost. It is a subdermal single-rod implant containing 68 mg of the progestin etonogestrel, which is highly effective in preventing pregnancy for a period of 3 years [2,3,4]. Despite the robust and supportive policies related to LARCs in the public sector, the use of the contraceptive implant among women is limited [5,6,7].
Among women, limited knowledge and awareness of the different contraceptive methods, including the implant, have been identified . Additionally, concerns, myths and misconceptions about side effects and risks associated with the implant contribute to the limited uptake among women [8,9,10]. Research conducted among men on family planning use and support remains insufficient globally . The few studies that have been conducted among men, show that male partner support for family planning influences women’s behaviour towards the use of modern contraceptives [11,12,13,14]. One study has been undertaken among women showing that beliefs about and perceptions of the implant’s side effects negatively influence men’s support for its use by their female intimate partners . Another South African study found that women report lack of male partner support for the use of the implant as one of the reasons for early removal and discontinuation of use .
This study aims to describe the specific factors affecting men’s support for the future use of the contraceptive implant by their female intimate partners. Such an understanding can complement the women’s perceptions of male partner support for family planning use and help design specific interventions to ameliorate the challenges affecting the implant use among women. Improving the implant uptake may significantly reduce unintended pregnancies which are highly prevalent among adolescents and adults in the country [7, 17]. Ultimately, this study hopes to contribute towards the intervention program development for the reduction of unplanned and or unintended pregnancies, as well as the unmet need for contraception in the country.
Research design and study setting
This quantitative, cross-sectional survey was conducted among adult men attending a public, primary health clinic in Cape Town, South Africa. The clinic was selected because it is a typical public clinic in a poor, peri-urban setting. It offered a range of public primary health services with a primary focus on STI, HIV and Tuberculosis (TB) services, including other sexual and reproductive health services. It is worth noting that historically, men poorly attend health care facilities and often delay seeking health care services when they are ill for various reasons, such as discomfort with female staff nurses, clinics being full of women, and fear of being labelled as “weak” according to gender norms [18,19,20]. Consequently in South Africa, “men only” clinics were initiated to help attract more men seeking health care service, particularly for STI testing and treatment including HIV services. This specific clinic, though not a “specialized” male clinic, it also had a “men only” section for STI treatment with dedicated male providers. Despite this effort, there were still few men attending the clinic.
All men aged 18 years and above who were attending the clinic between February 2015 to February 2016 for sexual and reproductive health related services, including HIV and TB testing and treatment were invited to participate in this study. Although this study was conducted in a public health clinic which also included a “men only” section, very few men visited the clinic. Additionally, to be invited in the study, men had to be able to read and write in English or isiXhosa; not psychologically and or visually impaired. Hence, only 71 men were approached and recruited for this study over this period. Of the 71 sampled participants, 65 agreed to participate and completed the self-administered questionnaire. Those who declined to participate cited time constraints as the main reason.
Data collection tool
A paper-pencil questionnaire format, requiring approximately 10 min for completion, was used to collect data. Participants could complete it in their preferred language (either English or Xhosa). Because of the sensitive nature of the questions, we offered self-administered survey completion to give participants privacy to answer the questions as truthfully as possible.
Demographic questions included marital or relationship status, and whether they had main or casual sex partners, or both. A main sexual partner was defined as a sexual partner an individual has for six or more months and included wives while a casual partner was defined as a “secret” sexual partner an individual has sex with occasionally and included the “one-night-stands”.
We included questions on partner’s use of family planning methods, as well as knowledge and awareness of, and outcome expectancies related to the contraceptive implant. We also included questions about the number of pregnancies for the female intimate partner, and fertility intentions. We asked whether participants had heard of each of the different types of contraceptive methods, the sources of information about each method (health worker, friend, media, other), and whether the participant knew if his female intimate partner had ever used each method or was currently using it.
To assess knowledge of the contraceptive implant, participants were provided with a set of six statements regarding the safety (e.g., ‘Most women can safely use the implant’) and efficacy of the implant (e.g., ‘The implant is very effective in preventing pregnancy). A three-point Likert scale was used (agree, disagree, and unsure). The internal consistency of the knowledge composite scale was adequate (Cronbach’s Alpha: 0.64; 95% Confidence Interval (95% CI): 0.60–0.69).
To measure outcome expectancies of the contraceptive implant, participants were asked to imagine how it would be like for them if their female intimate partners were to use the implant. They were provided with eleven (11) statements each reflecting a positive or negative outcome expectancy (e.g., ‘I think that if my partner were to use the implant it would be very good because it lasts for a long time’ [positive] and ‘I think that if my partner were to use the implant, the implant would move around her body [negative]). A three-point Likert scale was used (agree, disagree, or unsure). Finally, to measure men’s support for their female intimate partners to use the implant in the future, participants were asked whether they would like their partners to use the implant in the future (response options: yes, no, or unsure). The implant was defined to the participants as a small plastic rod inserted under the skin of a woman’s arm to prevent pregnancy. A copy of the questionnaire with the full statements is provided as an additional file [Additional file 1: Questionnaire]. Participants were offered a nominal reimbursement, a chocolate bar, for their time taken completing the survey.
Prior to analysis, items were rescored so that the valid knowledge statements and positive attitudes scored highest. Separate total scale scores were composed from the six items of knowledge composite and from the 11 items of the men’s outcome expectancy composite for the implant use by their female intimate partners. However, the scale scores were not used in the analyses due to the low internal reliability as indicated by the Cronbach’s Alpha statistic.
Data were analyzed using SPSS version 25. Descriptive statistics were performed to get an overview of the sample characteristics. A chi-square test was conducted to explore the associations between the demographic characteristics, knowledge scale, outcome expectancy items, and whether or not the men would like their female intimate partners to use the implant in the future. Significance level was set at p- value of equal to, or less than 0.05 (p ≤ 0.05). Prior to conducting the chi-square test, some variables were collapsed to become dichotomous variables. This was done in order to ascertain non-violation of the minimum expected cell frequency for the chi-square test. Thus, a 2 by 2 table design was used in this study.
A total of 65 men aged from 19 to 52 years with the mean (SD) of 31.2 (8.4) participated in this study. A small proportion, 23.1% (n = 15) were 24 years old or younger. Most had not completed secondary education (41.5%; n = 30) and 38.5% (n = 25) had completed secondary schooling. Only 15.4% (n = 10) had post-secondary school education. Most participants, 59.4%, (n = 38) reported they were unemployed. Most men, 87.2% (n = 56) were unmarried, but 81.3% (n = 52) reported to have a main sex partner and 43.8% (n = 28) reported to have a casual sex partner, while 18.8% (n = 12) did not have a main or casual partner. The reported reasons for being at the clinic on the day were for STI treatment by 61.5% (n = 40), 35.4% (n = 23) for an HIV test, and 4.6% (n = 3) for family planning.
Most participants, 76.6% (n = 49) endorsed the statement that both men and women should be responsible for family planning and 73.8% (n = 48) believed that men and women should decide together whether a woman should use contraception or not. Support for general contraception use by their female intimate partners was prevalent at 80.0% (n = 54). Awareness of the implant among men was relatively low, with 52.3% (n = 34) reporting they had never heard of the implant. Among those who had heard about the implant, 51.6% (n = 15) had heard about it from a friend, 32.3% (n = 10) from the healthcare worker and 32.3% (n = 10) from had heard about it from the media. Only 12.3% (n = 8) reported that their partners had used the implant before while the majority, 47.7% (n = 31) said their partners had never used the implant to their knowledge, and 38.5% (n = 25) said they did not know if their partners had ever used it. After having been informed by the data collector about the implant, 33.9% (n = 20) reported that they would like their partners to use the implant in the future, while 35.6% (n = 21) were unsure and 30.5% (n = 18) said they would not like their partners to use it.
Table 1 below compares men who reported they supported their partner using the implant in the future with those who did not support it or were unsure. Factors significantly associated with men’s support included men’s reports that their partner wished to have another child in future, knowledge that the implant is safe for use by women who have not had children, knowledge that the implant can effectively prevent pregnancy for 3 years, and the positive expectancy of the implant’s long-lasting effectiveness.
This study investigated factors associated with men’s support for the future use of the implant by their female intimate partners. Among the men, there were relatively low levels of awareness about the implant and minimal support for its future use by their female intimate partners. However, support for general contraceptive use was high among the men in this study. Factors associated with men’s support for the future use of the implant by their female intimate partners included: a) men knowing that the intimate partner wishes to have another child in future, b) knowing that the implant is safe for use by women who have not had children yet, c) knowing the timeframe within which the implant can effectively prevent pregnancy, and d) the perception that the implant last long. These findings are not unique, previous studies conducted elsewhere among men on women’s contraceptive use also identified a strong association between men’s awareness of contraceptive methods and their support for female intimate partner use [21,22,23,24,25,26,27,28]. Furthermore, men’s awareness of and support for modern contraceptive use was strongly associated with women’s desire to use contraception in Nigeria , and in Uganda . Potentially, men may play an essential role in some women’s decision to use or not use contraception. Therefore, to improve men’s support for the use of the contraceptive implant by their female intimate partners, they need to be engaged with as well if efforts to improve the uptake of the implant among women in the country are to be realized. Thus, efforts to improve men’s knowledge and awareness of the implant could potentially improve women’s utilization of the contraceptive implant.
It is not clear why men who believe their partners want to have children in the future would be more likely to support the implant use. It is possible that the men’s fertility intentions were not aligned to their partner’s intentions, and they regarded the implant as an effective contraception. It is equally plausible that they supported their partner’s use of the implant because of its reversable attribute, enabling their partner to become pregnant when the couple so desired.
It is well known that more women than men attend health facilities for reproductive healthcare services including family planning, but very little is being done to improve men’s participation and involvement in reproductive health programmes in the country. Men do not come with their female intimate partners for family planning . Therefore, most men, as well as some women generally have insufficient knowledge and understanding of female contraceptive methods, including the implant but men are hardly ever reached compared to women and continue to be distant in family planning programming. The findings of our study suggest the importance of actively engaging men in reproductive health and family planning programs, and the potential that men’s support could have on improving contraceptive use among women.
There are, of course, some important limitations in interpreting the findings of this study. The cross-sectional nature of the study being the first important one, cannot infer causality, meaning that improving men’s knowledge and awareness of the contraceptive implant will not necessarily result to improved uptake of the implant by the women. The other limitations are the small sample size of the men in this study, as well as the setting in which this study was undertaken and therefore, the findings cannot be generalizable. It is possible that most men were attending the “specialized” men only clinics where they will not be seen by female providers as well as not be amongst the many female patients who are filling up the waiting rooms in public health facilities . Despite these limitations, the findings of this study highlight the need and importance of actively engaging men in reproductive health programming to improve contraceptive uptake and reduce the unmet need for contraception among women of reproductive age.
Men’s perceptions about the implant’s safety and long-lasting characteristics are associated with their support for the future use of the implant by their female intimate partners. Thus, improving knowledge and awareness of the contraceptive implant among men may be a step in the right direction towards improving the uptake of the implant by women in the country. Unless men are well-informed and involved in reproductive health or family planning programming, support for their female intimate partners to use contraception will remain a challenge for many women. Interventions and strategies to engage men in family planning programs and enhance their participation in these programs are needed.
Availability of data and materials
The dataset used for the current study is available from the corresponding author on reasonable request.
- Cu IUD:
Copper Intrauterine Device
Human Immunodeficiency Virus
Long-Acting and Reversible Contraceptives
Sexually Transmitted Infections
Statistical Package for the Social Sciences
National Department of Health. National Contraception and Fertility Planning Policy and Services Delivery Guidelines: A Companion to the National Contraception Clinical Guidelines. Pretoria: Department of Health; 2014..
Patel M. Contraception: Everyone’s responsibility. S Afr Med J. 2014;104(9):644. https://doi.org/10.7196/SAMJ.8764.
Rowlands S, Searle S. Contraceptive implants. Curr Perspect. 2014;5:73–84. https://doi.org/10.2147/OAJC.S55968.
Dickerson LM, Diaz VA, Jordon J, et al. Satisfaction, early removal, and side effects associated with longacting reversible contraception. Fam Med. 2013;45(10):701–7.
Adeagbo OA, Mullick S, Pillay D, et al. Uptake and early removals of Implanon NXT in South Africa: perceptions and attitudes of health workers. S Afr Med J. 2017;107(10):822–6. https://doi.org/10.7196/SAMJ.2017.v107i10.12821.
Mullick S, Chersich MF, Pillay Y, Rees H. Introduction of the contraceptive implant in South Africa: successes, challenges and the way forward. S Afr Med J. 2017 Oct;107(10):812–4.
Chersich MF, Wabiri N, Risher K, Shisana O, Celentano D, Rehle T, et al. Contraception coverage and methods used among women in South Africa: a national household survey. S Afr Med J. 2017;107(4):307–14. https://doi.org/10.7196/SAMJ.2017.v107i4.12141.
Foster DG, Barar R, Gould H, Gomez I, Nguyen D, Biggs MA. Projections and opinions from 100 experts in long-acting reversible contraception. Contraception. 2015;92(6):543–52.
Garrett CC, Keogh LA, Kavanagh A, Tomnay J, Hocking JS. Understanding the low uptake of long-acting reversible contraception by young women in Australia: a qualitative study. BMC Womens Health. 2015;15(1):72.
Spies EL, Askelson NM, Gelman E, Losch M. Young women’s knowledge, attitudes, and behaviors related to long-acting reversible contraceptives. Womens Health Issues. 2010;20(6):394–9.
Marshall CJ, Gomez AM. Young men’s awareness and knowledge of intrauterine devices in the United States. Contraception. 2015;92(5):494–500.
Oyediran KA, Ishola GP, Feyisetan BJ. Factors affecting ever-married men’s contraceptive knowledge and use in Nigeria. J Biosoc Sci. 2002;34(4):497–510.
Duze MC, Mohammed IZ. Male knowledge, attitude, and family planning practices in northern Nigeria. Afr J Reprod Health. 2006;10(3):53–65.
Mesfin G. The role of men in fertility and family planning program in Tigray region. Ethiop J Health Dev. 2002;16(3):247–55.
Pillay D, Chersich MF, Morroni C, et al. User perspectives on Implanon NXT in South Africa: a survey of 12 public-sector facilities. S Afr Med J. 2017;107(10):815–21. https://doi.org/10.7196/SAMJ.2017.v107i10.12833.
Pillay D, Morroni C, Pleaner M, Adeagbo OA, Chersich MF, Naidoo N, et al. Gaps in monitoring systems for Implanon NXT services in South Africa: an assessment of12 facilities in two districts. S Afr Med J. 2017;107(10):827–31.
National Department of Health (NDoH), Statistics South Africa (Stats SA), South African Medical Research Council (SAMRC), and ICF. South Africa demographic and health survey 2016. Pretoria: NDoH, Stats SA, SAMRC, and ICF; 2019.
Orner P, Cooper D, Myer L, Zweigenthal V, Bekker LG, Moodley J. Clients’ perspectives on HIV/AIDS care and treatment and reproductive health services in South Africa. AIDS Care. 2008;20(10):1217–23.
Leichliter JS, Paz-Bailey G, Friedman AL, Habel MA, Vezi A, Sello M, Farirai T, Lewis DA. ‘Clinics aren’t meant for men’: Sexual health care access and seeking behaviours among men in Gauteng province, South Africa. SAHARA J. 2011;8(2):81–8.
Braitstein P, Boulle A, Nash D, Brinkhof MW, Dabis F, Laurent C, Schechter M, Tuboi SH, Sprinz E, Miotti P, Hosseinipour M. Gender and the use of antiretroviral treatment in resource-constrained settings: findings from a multicenter collaboration. J Women's Health. 2008;17(1):47–55.
Ezeanolue EE, Iwelunmor J, Asaolu I, Obiefune MC, Ezeanolue CO, Osuji A, et al. Impact of male partner’s awareness and support for contraceptives on female intent to use contraceptives in Southeast Nigeria. BMC Public Health. 2015;15(1):879.
Le Guen M, Ventola C, Bohet A, Moreau C, Bajos N. Men's contraceptive practices in France: evidence of male involvement in family planning. Contraception. 2015;92(1):46–54.
Nguyen BT, Shih G, Turok DK. Putting the man in contraceptive mandate. Contraception. 2014;89(1):3–5.
Mishra A, Nanda P, Speizer IS, Calhoun LM, Zimmerman A, Bhardwaj R. Men’s attitudes on gender equality and their contraceptive use in Uttar Pradesh India. Reprod Health. 2014;11(1):41.
Shattuck D, Kerner B, Gilles K, Hartmann M, Ng'ombe T, Guest G. Encouraging contraceptive uptake by motivating men to communicate about family planning: the Malawi male motivator project. Am J Public Health. 2011;101(6):1089–95.
Anguzu R, Tweheyo R, Sekandi JN, Zalwango V, Muhumuza C, Tusiime S, Serwadda D. Knowledge and attitudes towards use of long acting reversible contraceptives among women of reproductive age in Lubaga division, Kampala district, Uganda. BMC Res Notes. 2014;7(1):153.
Ijadunola MY, Abiona TC, Ijadunola KT, Afolabi OT, Esimai OA, OlaOlorun FM. Male involvement in family planning decision making in Ile-Ife, Osun state, Nigeria. Afr J Reprod Health. 2010;14(4):45–52.
Vouking MZ, Evina CD, Tadenfok CN. Male involvement in family planning decision making in sub-Saharan Africa-what the evidence suggests. Pan Afr Medi J. 2014;19.
We thank Sekelwa Dumile, Amanda Mdlikiva, Brenda Skonje and Thembinkosi Mdlikiva for collecting the data; and the clinicians who referred their patients to participate in our study.
This research was supported by a grant from the National Institute of Health under award number R01HD074560. This research was also supported by funding from the South African Medical Research Council.
Ethics approval and consent to participate
Permission to conduct the study was obtained from the South African Medical Research Council’s Ethics Committee (EC018–10/2013) and the University of Connecticut Institutional Review Board (H12–340).
Consent for publication
The authors declare that they have no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Jonas, K., Kalichman, M., Kalichman, S. et al. Factors affecting men’s support for the use of the contraceptive implant by their female intimate partners. Contracept Reprod Med 5, 36 (2020). https://doi.org/10.1186/s40834-020-00140-7
- Long-acting reversible contraceptives (LARCs)
- Contraceptive implant
- Implanon NXT
- Family planning
- Men’s support